Reagents & Solutions
800-356-9526
608-274-4330
enotes@promega.com
|
|
 |
|
Prions: The Unfolding Story of a Good Protein Gone Bad
Part I: Introduction to Prion Diseases and Biology
Spongiform
encephalopathies, or prion diseases, have captured the imaginations of
scientists and non-scientists alike. These diseases are unusual because
they are both heritable and transmissible. Additionally the proposed
causative agent is not a living organism and doesn't even require a nucleic
acid to wreak its havoc. It is merely a small, misfolded protein—one
that sticks to metal and plastic, is resistant to heat, protease, and
other typical sterilization methods. And, even more intriguing, this
misfolded protein seems to be able to jump the species barrier to cause
disease, perhaps even from cattle to humans.
This online serial
feature will explore prion biology and diseases, take a historical look
at the history of prions, and discuss the technologies and future science
coming out of current prion research. Installment
I: Introduction to Prion Diseases and Biology A
Brief History of Prions
Overview of Prion Diseases
Prion Structure and Function |
A Brief History of Prions
In 1939, sheep in Scotland were vaccinated against
“looping ill.” The vaccine,
prepared from formaldehyde-treated sheep brain extract, contained a hidden
infectious agent. This agent retained infectivity even after formaldehyde
treatment, and it transmitted Scrapie, a devastating neurological disease, to
10% of the vaccinated sheep (1).
Spongiform encephalopathies are neurological diseases that
are unusual because they are both inherited and infectious. The diseases
primarily affect the central nervous system, resulting in many large vacuoles
(holes)—giving the brain the appearance of a sponge. These diseases affect a
wide variety of species including humans, cattle, cats, sheep, deer, and many
others. The diseases are not caused by a bacterium—or a virus—or anything
containing nucleic acid. They appear to be caused by nothing more than a
misfolded protein, called a prion (proteinaceous infectious only;
2). In addition, prions can apparently cross species barriers.
In 1986, BSE (bovine spongiform encephalopathy
or “mad cow disease”), a prion disease of cattle was described in England (3).
The symptoms in affected cattle included rapidly changed behavior, inability to
stand, and reduced sensation. When the epidemic peaked in 1993, an estimated 1.2
million animals were possibly infected, and the meat of about 730,000 BSE-infected
cows had entered the human food chain (3). Exports of beef from the United
Kingdom were halted, and entire herds of cattle were destroyed to prevent the
spread of the disease. The economic cost was huge.
Recently thousands of elk and deer in Colorado and
Wisconsin have been destroyed to prevent the spread of chronic wasting disease.
The impact on the hunting and tourism industries in these states, not to mention
the food banks that rely on venison donations from hunters, remains to be
assessed.
Overview of Human Prion Diseases
Among the first human spongiform encephalopathies described
was KURU, a National Geographic “curiosity” limited to a distant
third-world, cannilbalistic tribe—certainly not a threat to first-world
inhabitants. One inherited form of human prion disease, Creutzfeldt-Jacob
Disease (CJD) was described prior to 1922, but only later was it recognized as a
prion-caused disease (4). Still, the inherited cases were rare and believed not
to be transmissible, so the perceived threat was minimal. Then in 1996, new
variant CJD (vCJD) was described based on 10 cases in Britain; scientists have
now described over 100 cases of vCJD in the United Kingdom, Ireland and France.
Unlike CJD or KURU however, vCJD was a different threat because it was linked to
BSE in cattle.
The strain properties of vCJD, which include the pattern of
tissue destruction and the disposition of clumps of protein in the nervous
tissue, are very similar between vCJD of humans and BSE of cattle (4).
Biochemical studies to determine the pattern of proteolytic digestion of vCJD
and BSE prions indicate that they are virtually indistinguishable (4). The
epidemiology of vCJD also supports a link between the disease in cattle and
humans. For instance, no confirmed cases of vCJD occur in geographic areas that
are free of BSE, and the highest prevalence of vCJD occurs in areas with the
highest prevalence of BSE (4,5). Because
the incubation period of vCJD is so long, with years between
ingesting the infected meat and developing clinical symptoms (5), researchers
have not definitely linked BSE with vCJD.
Prion Structure and Function
Prions have been found in species from yeast to humans.
The human protein is a 250-amino acid, GPI-linked (glycosyphosphatidylinositol-linked)
membrane protein called PrPc
(cellular Prion). It is encoded by the Prn-p gene and is highly expressed
in the central nervous system with lower levels of expression in immune cells
and muscle. Structurally the normal protein consists of three alpha helices with
a C-terminal gobular domain. Its expression in cells is highly regulated during
development and is influenced by Nerve Growth Factor (1,6).
PrPsc (the pathogenic form) is identical to PrPc at the
amino acid sequence level, however its secondary and tertiary structure is
different. PrPsc has a high beta sheet content, is detergent insoluble,
and is partially protease resistant. It is also resistant to heat and
irradiation.
Very little is known about the normal cellular function of
the prion protein. PrPc-null mice appear to develop normally, and
they are not susceptible to disease when challenged with the disease-causing
form of the protein (PrPsc; 1). PrPc has a high affinity
for laminin and may be important for cell adhesion, differentiation and
survival. Additionally, neurons lacking PrPc seem to be more
sensitive to oxidative stress (6). Since prions are found in species
from yeasts to humans, prions may play a fundamental biological role in cells,
but the nature of that role is unknown.
Current thought suggests that the misfolded PrPsc acts as a
template to direct normal cellular proteins to assume its pathogenic, abnormal
structure. Once this has happened, the proteins lose their ability to function
normally and begin to form aggregates in the nervous tissue, ultimately leading
to the spongiform disease.
Read the other installments in this series.
References
- Weissmann, C. et al. (2002) Transmission of prions. Proc. Natl.
Acad. Sci. Early Edition http://www.pnas.org/cgi/doi/10.1073/pnas.172403799
(accessed October 7, 2002).
- Prusiner, S.B. (1982) Novel proteinaceous infectious particles cause Scrapie.
Science 216, 136-44.
- Glatzel, M. and Aguzzi, A. (2001) The shifting biology of prions. Brain
Res. Rev. 36, 214-48.
- Collinge, J. (2001) Prion diseases of humans and animals: Their causes and
molecular basis. Annu. Rev. Neurosci. 24, 519-50.
- Centers for Disease Control (2002) Questions and Answers Regarding Bovine
Spongiform Encephalopathy (BSE) and Creutzfeldt-Jakob Disease (CJD)www.cdc.gov/ncidod/diseases/cjd/bse_cjd_qa.htm (accessed October 7, 2002).
- Martins, V.R. et al. (2002) Cellular prion protein: On the road for
functions. FEBS Letters 512, 25-8.
|
|
|
